Barbier-Torres, L., Fortner, K. A., Iruzubieta, P., Delgado, T. C., Giddings, E., Chen, Y., . . . Rincón, M. (2020). Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nature Portfolio.
Cita Chicago Style (17a ed.)Barbier-Torres, Lucía, et al. Silencing Hepatic MCJ Attenuates Non-alcoholic Fatty Liver Disease (NAFLD) by Increasing Mitochondrial Fatty Acid Oxidation. Nature Portfolio, 2020.
Cita MLA (8a ed.)Barbier-Torres, Lucía, et al. Silencing Hepatic MCJ Attenuates Non-alcoholic Fatty Liver Disease (NAFLD) by Increasing Mitochondrial Fatty Acid Oxidation. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.